FDA Clearance Tracker · P000040-S014
GENESYS HTA SYSTEM
Last checked: Nov 20, 2026Latest source record: Apr 23, 2010 (this decision)Source: openFDAMethods & limitations
Decided
Apr 23, 2010
Approved
Time to decision
352 days
Received May 6, 2009. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P000040-S014
- Device name
- GENESYS HTA SYSTEM
- Applicant
- Axora Medical, Inc.
- Applicant location
- Jacksonville, FL
- Received
- May 6, 2009
- Decided
- Apr 23, 2010
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P000040
Device type
- Device type
- Device, thermal ablation, endometrial (MNB)
- Device class
- Class III
- Specialty
- Obstetrics & Gynecology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE ¿NEXT GENERATION¿ HTA SYSTEM WITH A REDESIGNED OPERATIONAL UNIT (CONTROL UNIT, POWER CORD, PEDESTAL, IV POLE) AND A MODIFIED STERILE PROCEDURE SET. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME GENESYS HTA SYSTEM AND IS INDICATED FOR ABLATION OF THE ENDOMETRIAL LINING OF THE UTERUS IN PREMENOPAUSAL WOMEN WITH MENORRHAGIA (EXCESSIVE UTERINE BLEEDING) DUE TO BENIGN CAUSES FOR WHOM CHILDBEARING IS COMPLETE.
Source documents
Other decisions for Axora Medical, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K260984 · Decided Aug 18, 2026 · 146 days after receipt
Device type: Hysteroscope (And Accessories) (HIH) · Obstetrics & Gynecology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.